Re:U.S. Life Expectancy Drops for Third Year in a Row (2018)
by chimeracoder on Wednesday July 03, 2019 @01:14PM
(#20346330)
> Last time I checked the Swizz, Germans and Brits were major players in drug and medical R and D.
Where do you think those European drug companies get the bulk of their revenues from to do that R&D in the first place?
They make their money off the U.S market!
> Drug development in the US is expensive due to the dysfunctionality that exists within the FDA.
No, drug development is expensive because it's expensive. The EMA & co. are not substantially different in their requirements and expense than the FDA is. Regardless, even still, half of the R&D conducted in the entire world is funded directly by the US.
Most of the important deep tech happens in university done by post grads, not by for-profit companies.
Drug development in the US is expensive due to the dysfunctionality that exists within the FDA.